MYELOFIBROSIS side effect
What is MYELOFIBROSIS ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
MYELOFIBROSIS and Recently Reported Side Effects
MYELOFIBROSIS and 15 most Active Side Effect polls
MYELOFIBROSIS and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with MYELOFIBROSIS
ANAGRELIDE ARANESP ARAVA EPOGEN FORTEO HYDROXYUREA IMATINIB INTRON MALARONE PEPCID PROCRIT REVLIMID THALOMID XAGRIDXagrid Side Effects Report #5786766-7
Physician from UNITED KINGDOM reported XAGRID problem on June 13, 2008. Male patient, 32 years of age, was treated with XAGRID. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, . XAGRID dosage: unknown. Patient recovered.
Anagrelide Side Effects Report #5786767-9
ANAGRELIDE HYDROCHLORIDE problem was reported by a Physician from UNITED KINGDOM on June 13, 2008. Female patient, 78 years of age, was treated with ANAGRELIDE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, . ANAGRELIDE HYDROCHLORIDE dosage: unknown. Patient recovered.
Anagrelide Side Effects Report #5786768-0
Physician from UNITED KINGDOM reported ANAGRELIDE HYDROCHLORIDE problem on June 13, 2008. Female patient, 40 years of age, was treated with ANAGRELIDE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, . ANAGRELIDE HYDROCHLORIDE dosage: unknown. Patient recovered.
Hydroxyurea Side Effects Report #5316628-0
HYDROXYUREA problem was reported by a Health Professional from JAPAN on May 03, 2007. Female patient, 59 years of age, was diagnosed with essential thrombocythaemia and was treated with HYDROXYUREA. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, . HYDROXYUREA dosage: unknown. During the same period patient was treated with MITOBRONITOL, BUSULFAN, RANIMUSTINE. Patient recovered.
Imatinib Side Effects Report #5317580-4
Health Professional from GERMANY reported IMATINIB MESYLATE problem on Apr 24, 2007. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, . IMATINIB MESYLATE dosage: unknown. Patient recovered.
Forteo Side Effects Report #5301061-8
FORTEO problem was reported by a Consumer or non-health professional from CANADA on Apr 04, 2007. Female patient, 84 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, . FORTEO dosage: unknown. During the same period patient was treated with DIOVAN, FOLIC ACID, LIPITOR, CALCIUM, VITAMIN D, HYDROXYCHLOROQUINE SULPHATE, PREDNISONE, ACETAMINOPHEN. Patient recovered.
Revlimid Side Effects Report #5671680-8
Physician from UNITED STATES reported REVLIMID problem on Mar 10, 2008. Male patient, 80 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN D, ORAL. Patient died on 02/04/2008.
Anagrelide Side Effects Report #5688192-8
ANAGRELIDE HYDROCHLORIDE problem was reported by a Physician from SWEDEN on Mar 12, 2008. Male patient was diagnosed with essential thrombocythaemia, myelofibrosis and was treated with ANAGRELIDE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: myelofibrosis, platelet count decreased, . ANAGRELIDE HYDROCHLORIDE dosage: 1.0 MG AM AND 2.0 MG EVENING, ORAL. During the same period patient was treated with PEGASYS. Patient recovered.
Revlimid Side Effects Report #5571116-1
Physician from UNITED STATES reported REVLIMID problem on Dec 13, 2007. Male patient, 78 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL; 10 MG, IN 1 IN D, ORAL. Patient died on 11/09/2007.
Revlimid Side Effects Report #5483612-6
REVLIMID problem was reported by a Physician from UNITED STATES on Oct 02, 2007. Female patient, 63 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, QD, ORAL. Patient died on 03/26/2007.
Imatinib Side Effects Report #5489047-4
Health Professional from GERMANY reported IMATINIB problem on Oct 09, 2007. Male patient, 50 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, myelofibrosis, platelet count decreased, splenomegaly, white blood cell count increased, . IMATINIB dosage: 400 MG/D. Patient recovered.
Revlimid Side Effects Report #5453517-5
REVLIMID problem was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Male patient, 68 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/06/2007.
Revlimid Side Effects Report #5471207-X
Physician from UNITED STATES reported REVLIMID problem on Sept 20, 2007. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome, myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 08/01/2007.
Intron Side Effects Report #5379335-4
INTRON A problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Female patient was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.
Intron Side Effects Report #5396876-4
Consumer or non-health professional from UNITED STATES reported INTRON A problem on July 17, 2007. Female patient, 54 years of age, weighting 115.0 lb, was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.
Intron Side Effects Report #5379335-4
INTRON A problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Female patient was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.
Intron Side Effects Report #5396876-4
Consumer or non-health professional from UNITED STATES reported INTRON A problem on July 17, 2007. Female patient, 54 years of age, weighting 115.0 lb, was diagnosed with polycythaemia vera and was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, . INTRON A dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5797778-1
REVLIMID problem was reported by a Physician from UNITED STATES on June 23, 2008. Male patient, 55 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.
Aranesp Side Effects Report #5709270-0
Physician from CANADA reported ARANESP problem on Apr 04, 2008. Female patient, child 11 years of age, was diagnosed with dialysis and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: metabolic disorder, myelofibrosis, therapeutic response decreased, . ARANESP dosage: unknown. Patient recovered.
Malarone Side Effects Report #5294620-2
MALARONE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 05, 2007. Male patient, 40 years of age, was diagnosed with malaria prophylaxis and was treated with MALARONE. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, splenomegaly, white blood cell disorder, . MALARONE dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5261924-9
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Mar 05, 2007. Male patient, 68 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/06/2007.
Thalomid Side Effects Report #5267147-1
THALOMID problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, myelofibrosis, . THALOMID dosage: 100 MG, DAILY, ORAL. Patient died on 02/15/2007.
Thalomid Side Effects Report #5285431-2
Physician from UNITED STATES reported THALOMID problem on Mar 20, 2007. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, myelofibrosis, pneumonitis, . THALOMID dosage: 100 MG DAILY ORAL. Patient was hospitalized. Patient died on 02/15/2007.
Thalomid Side Effects Report #5285882-6
THALOMID problem was reported by a Physician from UNITED STATES on Mar 20, 2007. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, myelofibrosis, pneumonitis, . THALOMID dosage: 100 MG, DAILY, ORAL. Patient was hospitalized. Patient died on 02/15/2007.
Revlimid Side Effects Report #5635795-2
Health Professional from SPAIN reported REVLIMID problem on Feb 15, 2008. Male patient was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG,DAILY,ORAL. Patient died.
Thalomid Side Effects Report #5481944-9
THALOMID problem was reported by a Physician from UNITED STATES on Oct 02, 2007. Female patient, 54 years of age, was diagnosed with myelofibrosis and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: disease progression, malaise, myelofibrosis, polycythaemia, respiratory arrest, . THALOMID dosage: 50 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 09/07/2007.
Procrit Side Effects Report #5772567-2
Physician from UNITED STATES reported PROCRIT problem on June 05, 2008. Female patient, weighting 140.2 lb, was diagnosed with anaemia and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: breast cancer metastatic, metastases to bone, myelofibrosis, pancytopenia, . PROCRIT dosage: unknown. During the same period patient was treated with NEUPOGEN, LASIX, ZYRTEC, ALDACTONE, MORPHINE. Patient died on 01/22/2008.
Revlimid Side Effects Report #5796406-9
REVLIMID problem was reported by a Pharmacist from UNITED STATES on June 30, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, liver disorder, myelofibrosis, neuropathy peripheral, thrombocytopenia, . REVLIMID dosage: 5MG DAILY PO. During the same period patient was treated with DANAZOL. Patient recovered.
Epogen Side Effects Report #5732154-9
Physician from UNITED STATES reported EPOGEN problem on Apr 28, 2008. Female patient, 46 years of age, was diagnosed with dialysis and was treated with EPOGEN. After drug was administered, patient experienced the following problems/side effects: anti-erythropoietin antibody positive, hyperparathyroidism secondary, myelofibrosis, non-neutralising antibodies positive, therapeutic response decreased, . EPOGEN dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5705500-X
REVLIMID problem was reported by a Physician from UNITED STATES on Apr 04, 2008. Male patient, 77 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, myeloid metaplasia, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/06/2008.
Anagrelide Side Effects Report #5715764-4
Physician from SWEDEN reported ANAGRELIDE HYDROCHLORIDE problem on Apr 08, 2008. Male patient, 68 years of age, was diagnosed with essential thrombocythaemia, myelofibrosis and was treated with ANAGRELIDE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, myelofibrosis, platelet count increased, therapeutic response delayed, thrombocytopenia, . ANAGRELIDE HYDROCHLORIDE dosage: 1.0 MG AM AND 2.0 MG EVENING, ORAL. During the same period patient was treated with PEGASYS. Patient recovered.
Revlimid Side Effects Report #5725856-1
REVLIMID problem was reported by a Physician from UNITED STATES on Apr 16, 2008. Male patient, 69 years of age, was diagnosed with myelodysplastic syndrome, myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, myelodysplastic syndrome, myelofibrosis, pulmonary embolism, pulmonary infarction, refusal of treatment by patient, splenomegaly, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL; 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Pepcid Side Effects Report #5299298-X
Physician from JAPAN reported PEPCID RPD problem on Apr 10, 2007. Female patient, 67 years of age, was diagnosed with reflux oesophagitis, myeloproliferative disorder, bronchitis, enterocolitis, gastritis, hypothyroidism, angina pectoris, post cholecystectomy syndrome and was treated with PEPCID RPD. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, klebsiella infection, myelofibrosis, renal failure acute, sepsis, . PEPCID RPD dosage: unknown. During the same period patient was treated with MUCOSOLVAN, BIOFERMIN, SELBEX, THYRADIN, FRANDOL. Patient was hospitalized. Patient recovered.
Arava Side Effects Report #5259848-6
ARAVA problem was reported by a Physician from SOUTH AFRICA on Mar 06, 2007. Female patient, 64 years of age, was diagnosed with rheumatoid arthritis, menopause, hypertension and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: anaemia megaloblastic, mycobacterial infection, myelofibrosis, . ARAVA dosage: unknown. During the same period patient was treated with METHOTREXATE, ACTIVELLE, DYNACIRC, FOLIC ACID, CELEBREX, NEXIAM. Patient recovered.
Thalomid Side Effects Report #5285433-6
Physician from UNITED STATES reported THALOMID problem on Mar 23, 2007. Female patient, 77 years of age, was diagnosed with myelofibrosis and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, disease progression, myelofibrosis, . THALOMID dosage: 50 MG DAILY ORAL. Patient died on 02/01/2007.